Literature DB >> 7495922

Language comprehension in schizophrenia: trait or state indicator?

R Condray1, D P van Kammen, S R Steinhauer, A Kasparek, J K Yao.   

Abstract

Language comprehension, measured by the Luria-Nebraska Relational Concepts Factor Scale, was evaluated twice in 15 male DSM-III-R schizophrenic patients during a controlled double-blind haloperidol maintenance (without anticholinergics) and placebo replacement protocol. Fifteen male normal controls were tested once. Patients and controls were matched on age and education. Language comprehension was significantly reduced in patients under both pharmacologic conditions, as compared with controls. Patients' comprehension accuracy did not differ significantly between neuroleptic-treatment and placebo replacement conditions. Patients' comprehension accuracy was independent of positive symptoms, anxiety-depression, measures of clinical course, and CSF and plasma monoamines. Comprehension accuracy was also not associated with patients' educational level or WAIS-R measures of their intellectual and short-term memory functioning. Patients' comprehension performance was significantly associated only with the negative symptom anhedonia-asociality during haloperidol maintenance. Thus, language comprehension in schizophrenic patients was independent of changes in pharmacologic treatment and the positive symptoms of psychosis. Results suggest language comprehension may represent a stable or trait characteristic in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7495922     DOI: 10.1016/0006-3223(95)00378-T

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  7 in total

Review 1.  Cognitive control deficits in schizophrenia: mechanisms and meaning.

Authors:  Tyler A Lesh; Tara A Niendam; Michael J Minzenberg; Cameron S Carter
Journal:  Neuropsychopharmacology       Date:  2010-09-15       Impact factor: 7.853

2.  Reduction in perseverative errors with adjunctive ethyl-eicosapentaenoic acid in patients with schizophrenia: Preliminary study.

Authors:  R Reddy; S Fleet-Michaliszyn; R Condray; J K Yao; M S Keshavan; R Reddy
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2011-01-05       Impact factor: 4.006

3.  Disordered discourse in schizophrenia described by the Structure Building Framework.

Authors:  Morton Ann Gernsbacher; Kathleen A Tallent; Caroline M Bolliger
Journal:  Discourse Stud       Date:  1999-08

Review 4.  Exploring predictors of outcome in the psychosis prodrome: implications for early identification and intervention.

Authors:  Tara A Niendam; Maria Jalbrzikowski; Carrie E Bearden
Journal:  Neuropsychol Rev       Date:  2009-07-14       Impact factor: 7.444

5.  Processing of linguistic deixis in people with schizophrenia, with and without auditory verbal hallucinations.

Authors:  Paola Fuentes-Claramonte; Joan Soler-Vidal; Pilar Salgado-Pineda; Nuria Ramiro; Maria Angeles Garcia-Leon; Ramon Cano; Antonio Arévalo; Josep Munuera; Francisco Portillo; Francesco Panicali; Salvador Sarró; Edith Pomarol-Clotet; Peter McKenna; Wolfram Hinzen
Journal:  Neuroimage Clin       Date:  2022-04-13       Impact factor: 4.891

6.  Social cognition in schizophrenic patients: the effect of semantic content and emotional prosody in the comprehension of emotional discourse.

Authors:  Perrine Brazo; Virginie Beaucousin; Laurent Lecardeur; Annick Razafimandimby; Sonia Dollfus
Journal:  Front Psychiatry       Date:  2014-09-10       Impact factor: 4.157

7.  Pars Triangularis Volume Asymmetry and Schneiderian First Rank Symptoms in Antipsychotic-naïve Schizophrenia.

Authors:  Venkataram Shivakumar; Vanteemar Sathyanarayana Sreeraj; Sunil Vasu Kalmady; Bangalore Nanjundaiah Gangadhar; Ganesan Venkatasubramanian
Journal:  Clin Psychopharmacol Neurosci       Date:  2021-08-31       Impact factor: 2.582

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.